Old Web
English
Sign In
Acemap
>
authorDetail
>
I.E. James
I.E. James
Trevena Inc
Bioavailability
Pharmacokinetics
Medicine
Tolerability
Opioid
2
Papers
15
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A Phase I, Randomized, Single‑Blind, Placebo‑Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Oral TRV250, a G Protein-Selective Delta Receptor Agonist, in Healthy Subjects.
2020
CNS Drugs
Michael J. Fossler
Virginia D. Schmith
Stephen A. Greene
Lauren R. L. Lohmer
Michael S. Kramer
Kelly A. Arscott
I.E. James
Mark A. Demitrack
Show All
Source
Cite
Save
Citations (5)
A First‐in‐Human Clinical Study With TRV734, an Orally Bioavailable G‐Protein–Biased Ligand at the μ‐Opioid Receptor
2019
Clinical pharmacology in drug development
I.E. James
Franck Skobieranda
David G. Soergel
Kimberly A. Ramos
Dennis Ruff
Michael J. Fossler
Show All
Source
Cite
Save
Citations (10)
1